Roman Butler Fullerton & CO Regeneron Pharmaceuticals, Inc. Transaction History

Roman Butler Fullerton & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$680.49 - $826.97 $79,617 - $96,755	117 Added 8.22%	1,541 $1.27 Million
Q4 2022 Jan 23, 2023	SELL	$705.89 - $766.39 $283,767 - $308,088	-402 Reduced 22.02%	1,424 $0
Q3 2022 Oct 17, 2022	BUY	$573.97 - $724.32 $1.05 Million - $1.32 Million	1,826 New	1,826 $1.35 Million
Q4 2020 Feb 01, 2021	SELL	$478.3 - $607.98 $670,098 - $851,779	-1,401 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$493.32 - $643.92 $156,875 - $204,766	318 Added 29.36%	1,401 $874,000
Q1 2020 Apr 13, 2020	BUY	$336.18 - $494.43 $364,082 - $535,467	1,083 New	1,083 $529,000
Q1 2019 Apr 24, 2019	SELL	$372.08 - $439.57 $407,427 - $481,329	-1,095 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$335.82 - $403.04 $367,722 - $441,328	1,095 New	1,095 $447,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

Stay updated on Roman Butler Fullerton & CO with notifications on news.